What is the Blalock‑Taussig shunt?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

What is the Blalock-Taussig Shunt?

The Blalock-Taussig (BT) shunt is a palliative surgical procedure that creates a connection between the systemic arterial circulation and the pulmonary arteries to increase pulmonary blood flow in patients with cyanotic congenital heart disease, most commonly performed as a modified version using an interposition graft. 1

Historical Context and Evolution

The BT shunt was first described in 1945 and represented the first direct surgical procedure for treating cyanotic congenital heart disease. 2 Over more than six decades of use, the procedure has undergone significant modifications while remaining an integral component of managing cyanotic heart defects. 3

Types of Blalock-Taussig Shunts

Classic BT Shunt

  • Direct end-to-side anastomosis of the subclavian artery to the pulmonary artery 4
  • Historically more common but now largely replaced by the modified technique 5

Modified BT Shunt

  • Uses an interposition graft (typically expanded polytetrafluoroethylene) to connect the subclavian artery to the pulmonary artery 4, 1
  • Currently represents 99.6% of all BT shunts performed 3
  • The modified BT shunt is technically simpler with less dissection, preserves blood flow to the arm, and has demonstrated superior outcomes regarding hemodynamics, patency rate, and survival compared to the classic approach 1

Primary Indications

The BT shunt serves as a palliative procedure to augment pulmonary blood flow in several clinical scenarios:

  • Tetralogy of Fallot (TOF): The most common indication, particularly in symptomatic neonates where early complete repair is not feasible 6, 5
  • Single ventricle lesions: Increasingly used as part of staged palliation toward eventual Fontan completion 3, 5
  • Pulmonary atresia with ventricular septal defect 6
  • Complex cyanotic congenital heart defects with inadequate pulmonary blood flow 1, 3

Surgical Technique and Approach

Anatomic Considerations

  • Predominantly performed on the right side (90% of cases) 3
  • Most common configuration: right subclavian artery to right pulmonary artery 3
  • Can be performed via sternotomy (65% of cases) or thoracotomy (35% of cases) 3, 7

Approach-Related Outcomes

Thoracotomy approach demonstrates lower morbidity compared to sternotomy, with significantly shorter ventilation duration (53 hours vs 183 hours), reduced inotropic requirements (4.2% vs 33.3%), shorter ICU stay (3.3 days vs 9.14 days), and shorter hospital stay (5 days vs 14.59 days). 7

Contemporary Outcomes

Mortality

  • Modern operative mortality ranges from 1-9% in specialized centers 4, 3, 2
  • Hospital mortality is significantly higher in single ventricle patients compared to biventricular lesions (15% vs 3%) 3
  • Mortality is primarily related to patient condition at surgery and underlying cardiac pathology rather than age 2

Risk Factors for Mortality

Multivariable analysis identifies the following as independent risk factors for in-hospital mortality:

  • Sternotomy approach 3
  • Use of cardiopulmonary bypass 3
  • Innominate artery-to-pulmonary artery shunt configuration 3
  • Specific diagnoses such as Ebstein's anomaly 3

Role in Modern Management

For Tetralogy of Fallot

When palliation is chosen for symptomatic neonates with TOF, systemic-to-pulmonary shunt (most commonly modified BT shunt) is a reasonable strategy alongside alternatives including RVOT patch and right ventricle-to-pulmonary artery conduit (Class IIa recommendation). 6

The decision between palliation and primary repair depends on:

  • Patient age and weight 6
  • Severity of symptoms 6
  • Anatomy of pulmonary arteries 6
  • Institutional expertise 6

Advantages of BT Shunt

  • Excellent pulmonary artery growth observed in patients with modified BT shunt 1
  • Can be performed on patients of any age with minimum postoperative complications 1
  • Expanded polytetrafluoroethylene grafts have demonstrated satisfactory long-term patency 1
  • 73% of patients are successfully bridged to complete repair or second stage palliation after median duration of 6.5 months 3

Evolving Landscape

  • Decreasing overall use of BT shunts over time (from 66 per year to 9 per year comparing early vs late eras) 5
  • Shift toward transcatheter interventions (ductal stenting) in selected high-risk patients at centers with demonstrated expertise 6
  • Greater application to single-ventricle lesions in contemporary practice (34% vs 5% comparing recent vs historical eras) 5

Important Caveats

  • Single ventricle patients face significant ongoing mortality risk even after successful BT shunt placement 3
  • The procedure requires careful patient selection and timing, particularly when considering transcatheter alternatives 6
  • Institutional and surgeon experience significantly impacts outcomes 6, 1

References

1
Research

The Blalock-Taussig shunt.

Journal of cardiac surgery, 2009

3
Research

The Blalock-Taussig shunt revisited: a contemporary experience.

Journal of the American College of Surgeons, 2013

5
Research

Two thousand Blalock-Taussig shunts: a six-decade experience.

The Annals of thoracic surgery, 2007

Related Questions

What is the significance of a non‑dependent air‑fluid level in the bladder on computed tomography, and what diagnostic and therapeutic steps should be taken?
What are the differential diagnoses for unexplained ankle swelling and bruising?
A 70‑year‑old man experiences brief facial flushing and dizziness when bending forward or standing up from a seated position, without nausea, vomiting, or other symptoms; his examination shows normal seated and standing blood pressure and heart rate and otherwise normal findings. What is the likely cause and how should it be managed?
In a 79-year-old man presenting with shoulder and neck pain, sinus pressure above and below the eyes, left lower back pain worsened by deep inspiration, hypothermia, hypertension, and warm extremities, what emergent diagnosis should be considered and what immediate management is indicated?
What does a blunted left costophrenic angle with obscured left hemidiaphragm and left lower lung zone opacity indicate, and should I go to the emergency department immediately?
What is the appropriate management of a grade 1 diabetic foot ulcer?
Which neurotransmitter is primarily implicated in attention-deficit/hyperactivity disorder (ADHD)?
What diagnosis is associated with difficulty staying seated during meetings and persistent restlessness?
Can pseudoephedrine cause vertigo?
How can urine output be measured accurately in a patient with ongoing bladder irrigation fluid?
How do tumors cause an increase in intracranial pressure?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.